A liquid therapy placed underneath the tongues of people with peanut allergy can reduce their sensitivity to peanuts, a new study found. With further development, the experimental technique could make life easier for people whose only current option is to avoid everything that contains peanuts.
Food allergy comes about when the immune system responds to a harmless food as if it were a threat. Symptoms can range from hives and itching to a life-threatening condition called anaphylaxis, which can involve throat swelling, a sudden drop in blood pressure, trouble breathing, fainting and dizziness.
In both children and adults, peanuts are one of the most common foods to cause allergic reactions. About 3 out of every 500 people in the United States are allergic to peanuts. The only way to prevent the symptoms of food allergy is to avoid the food altogether. But it’s difficult to completely avoid exposure to peanuts and all the products made with them.
Recent studies have found that oral immunotherapy may hold promise for treating food allergy. A research team led by Dr. David M. Fleischer of National Jewish Health in Denver and Dr. A. Wesley Burks at the University of North Carolina set out to test whether an approach called sublingual immunotherapy could be used to treat peanut allergy. The medically supervised therapy involves placing a small amount of the allergy-causing substance (allergen) under the tongue to decrease the body’s sensitivity to the allergen.
The scientists enrolled 40 people, ages 12 to 37 years, with peanut allergy. All were on a peanut-free diet. After an initial food challenge to measure how much peanut powder they could eat without having an allergic reaction, participants were randomly assigned to receive sublingual immunotherapy or placebo. The therapy group received escalating doses of peanut powder every 2 weeks until a maintenance dose was reached. The trial was funded by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), National Center for Research Resources (NCRR) and National Center for Advancing Translational Sciences (NCATS). Results appeared in the January 2013 issue of the Journal of Allergy and Clinical Immunology.
The researchers found that 14 of the 20 participants (70%) given peanut immunotherapy were able to consume at least 10 times more peanut powder after 44 weeks of daily therapy than they could at the beginning of the study. In contrast, only 3 of the 20 participants (15%) given placebo could safely consume such an increase. After 68 weeks, those on immunotherapy could consume significantly more peanut powder without having an allergic reaction than those given placebo. The therapy caused only minor side effects, such as itching in the mouth.
With more work, the scientists hope that sublingual immunotherapy could protect people from unintentional exposure to peanuts. “These results are encouraging,” Burks says. “The immune response was stronger than we thought it might be, and the side effects of this treatment were relatively small. However, the magnitude of the therapeutic effect was somewhat less than we had anticipated. That’s an issue we plan to address in future studies.”
This is one of several federally funded trials currently testing immune-based approaches to food allergy. The researchers caution that people should not try any of these techniques on their own because they carry a significant risk for allergic reactions. These therapies should be administered only under the guidance of trained clinicians.
Learn more: Therapy Shows Promise for Peanut Allergy
The Latest on: Peanut immunotherapy
[google_news title=”” keyword=”peanut immunotherapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Peanut immunotherapy
- ‘Life-transforming’: British clinical trial shows hope for patients with peanut, food allergieson May 8, 2024 at 10:30 am
The Food Standards Agency said two million people in the UK have a diagnosed food allergy. In the U.S., about 5.5. million children have a food allergy, the National Institutes of Health reported.
- New treatment for children with nut and milk allergies hailed as 'a miracle' after trialson May 8, 2024 at 3:59 am
The new clinical oral immunotherapy trial is using everyday foods to build up an allergy patient's tolerance over time. Children who have been part of the trial have showed major improvements ...
- Children given trigger foods to treat serious milk and peanut allergies in 'miracle' NHS trialon May 8, 2024 at 2:41 am
Five NHS hospitals are taking part in the trial which could see more children with serious allergies eating wider varieties of food without ongoing fears and risks of accidental exposure.
- Scientists celebrate ‘first step’ in making food allergies historyon May 8, 2024 at 1:58 am
Scientists celebrate ‘first step’ in making food allergies history - To date, 139 people aged from two to 23 with allergies to peanuts or cow’s milk have started treatment ...
- NHS trial uses daily doses of food allergens to tackle severe reactionson May 7, 2024 at 8:00 pm
Life-transforming’ trial giving children and young people with milk or peanut allergy small doses to train their bodies to tolerate it ...
- Current and Emerging Immunotherapeutic Approaches to Treat and Prevent Peanut Allergyon May 7, 2024 at 5:00 pm
peptide immunotherapy has the potential to provide patients with a simple but highly targeted approach toward modulating the immune responses to peanut allergy. The results of coming clinical ...
- Health Beat: Toothpaste for peanut allergieson April 30, 2024 at 1:00 pm
One in 50 children in the United States is allergic to peanuts, while one in 200 adults have the allergy, too.
- Allergy Newson April 29, 2024 at 5:00 pm
Toddlers Allergic to Peanuts: Study Shows How Sublingual Immunotherapy Is Safe and Effective Oct. 14, 2023 — A clinical study showed how Peanut Sublingual Immunotherapy (Peanut SLIT) is safe and ...
- Your Good Health: Treatment for peanut allergies work in progresson April 12, 2024 at 11:29 pm
It would seem prudent to desensitize people who have allergies that are life-threatening, like peanut allergies. Allergy immunotherapy continues to be a commonly used and valid treatment for many ...
via Bing News